There was no significant difference in OS between HLA-A*2402 matched and unmatched stage IIIb CRC groups.
patients with HLA-A*2402 with positive CTL response
patients with HLA-A*2402 without positive CTL response
The 3-year elapse-free survival (RFS) in metastatic colorectal cancer (CRC)